天然糖苷配基,植物中含有糖苷的主要成分,在各种疾病的治疗中发挥了重要作用。然而,它们的生物利用度受其水溶性差的限制。与以前需要使用新的外来材料的努力相反,这些材料可能会引起对生物相容性的关注,我们报道了第一例无赋形剂纳米分散体,其中不溶性甘草次酸(GA)与其两亲性母体药物甘草酸二铵(DG)组装成水分散性纳米分散体(粒径为130.8nm,包封率为91.74%).该策略使GA的水表观溶解度大大提高了数百倍,达到549.0μg/mL,体外累积溶出百分比在5分钟内超过80%。形成机理的研究表明,OH,C-O和C=O基团拉伸峰在GA-DG纳米分散体的FTIR光谱中移动,而COOH峰(δCOOH12.19ppm)在GA-DG纳米分散体的1HNMR光谱中消失,表明GA上的羧基可以与溶液中DG的羟基相互作用。分子动力学模拟表明,疏水相互作用和氢键相互作用都有助于GA和DG分子在水溶液中的共组装。大鼠的口服药代动力学研究表明,与GA相比,这种纳米分散体的Cmax和AUC0-t显着增加2.45倍和3.45倍。分别。因此,这一战略,采用两亲性糖苷作为赋形剂来制备纳米分散体,不使用新材料,为疏水糖苷配基药物的进一步应用铺平了道路。
Natural aglycones, a major ingredient accompanied by glycosides in plants, have played an important role in the treatment of various diseases. However, their bioavailability is limited by their poor water solubility. In contrast to previous efforts that required the use of new exotic materials which may raise concerns about biocompatibility, we report the first
case of excipient-free nanodispersions in which an insoluble glycyrrhetinic acid (GA) assembled with its amphiphilic parent drug diammonium glycyrrhizinate (DG) into water-dispersible nanodispersions (130.8 nm for particle size and 91.74% for encapsulation efficiency). This strategy largely increased GA\'s water apparent solubility by hundreds of times to 549.0 μg/mL with a high cumulative dissolution percentage in vitro greater than 80% in 5 min. The study on the formation mechanism showed that the OH, C-O and C=O group stretching peaks shifted in the FTIR spectra of GA-DG nanodispersions, while the COOH peak (δ COOH 12.19 ppm) disappeared in the 1H NMR spectrum of GA-DG nanodispersions, indicating that carboxyl groups on GA may interact with the hydroxyl groups of DG in solution. Molecular dynamics simulations suggested that both hydrophobic interactions and hydrogen-bond interactions contribute to the coassembly of GA and DG molecules in aqueous solution. Oral pharmacokinetic studies in rats demonstrated that such nanodispersions have a significant increase in Cmax and AUC0-t of 2.45- and 3.45-fold compared with those for GA, respectively. Therefore, this strategy, employing amphiphilic glycosides as excipients to prepare nanodispersions, not using new materials, paves the way for the further application of hydrophobic aglycone drugs.